New test improves diagnosis of allergies.

A new test developed by researchers at the University of Bern offers a more accurate alternative to traditional methods for diagnosing peanut allergies. The Hoxb8 mast cell activation test (Hoxb8 MAT) mimics allergic reactions in a test tube, providing a higher diagnostic accuracy of 95% compared to standard tests. This innovative technology has the potential to simplify allergy diagnostics and improve patient outcomes, with the spinoff company ATANIS Biotech AG working towards certifying and marketing the test worldwide. [Extracted from the article]